<unk>  infarct seen on CT Healed<unk>  infarct Several factors may increase the tendency for clot formation, such as specific infections (such as infectious mononucleosis, cytomegalovirus infection, malaria, or babesiosis), inherited clotting disorders (thrombophilia, such as Factor V Leiden, antiphospholipid syndrome), malignancy (such as pancreatic cancer) or metastasis, or a combination of these factors. In some conditions, blood clots form in one part of the circulatory system and then dislodge and travel to another part of the body, which could include the spleen. These emboligenic disorders include atrial fibrillation, patent foramen ovale, endocarditis or cholesterol embolism.<unk>  is also more common in hematological disorders with associated splenomegaly, such as the myeloproliferative disorders. Other causes of splenomegaly (for example, Gaucher disease or hemoglobinopathies) can also predispose to<unk> .<unk>  can also result from a sickle cell crisis in patients with sickle cell anemia. Both splenomegaly and a tendency towards clot formation feature in this condition. In sickle cell disease, repeated<unk> s lead to a non-functional spleen (autosplenectomy). Any factor that directly compromises the<unk>  artery can cause<unk> . Examples include abdominal traumas, aortic dissection, torsion of the<unk>  artery (for example, in wandering spleen) or external compression on the artery by a tumor. It can also be a complication of vascular procedures.<unk>  can be due to vasculitis or disseminated intravascular coagulation. Various other conditions have been associated with<unk>  in case reports, for example granulomatosis with polyangiitis or treatment with medications that predispose to vasospasm or blood clot formation, such as vasoconstrictors used to treat esophageal varices, sumatriptan or bevacizumab. In a single-center retrospective cases review, people who were admitted to the hospital with a confirmed diagnosis of acute<unk> , cardiogenic emboli was the dominant etiology followed by atrial fibrillation, autoimmune disease, associated infection, and hematological malignancy. In spite of those already had risk factors of developing<unk> , there were nine beforehand healthy people. And among them, 5 of 9 hitherto silent antiphospholipid syndrome or mitral valve disease had been identified. Two remained cryptogenic. Therapeutic<unk> <unk>  can be induced for the treatment of such conditions as portal hypertension or<unk>  injury. It can also be used prior to<unk> tomy for the prevention of blood loss.
Splenic infarction
Splenic injury
Bowel infarction
Intestinal ischemia
Bowel obstruction
Pancreatic abscess
Pancreatic injury
Gastrointestinal perforation